References
- Westphal JF. (1991). Reappraisal of amoxicillin absorption kinetics. J Antimicrob Chemother, 27:647–54.
- Cortvriendt WRE. (1987). Bioavailability study of a new amoxicillin tablet designed for several modes of oral administration. Arzneimittelforschung/Drug Res, 37:977–81.
- Barr WH. (1994). Differential absorption of amoxicillin from the human small and large intestine. Clin Pharmacol Ther, 56:279–85.
- Wagner JG, Nelson E. (1963). Percent absorbed time plots derived from blood level and/or urinary excretion data. J Pharm Sci, 52:610–1.
- U.S. Food and Drug Administration (FDA). (1997). Guidance for Industry. Extended release oral dosage forms: Development, evaluation, and application of in vitro/in vivo correlations, U.S. Department of Health, Food and Drug Administration, Center for Drug Evaluation and Research, U.S. Food and Drug Adminstration, Rockville, MD.
- Erah PO. (1997). The stability of amoxicillin, clarithromycin and metronidazole in gastric juice: Relevance to the treatment of Helicobacter pylori infection. J Antimicrob Chemother, 39:5–12.